{
  "nctId": "NCT02012621",
  "briefTitle": "Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy",
  "officialTitle": "Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy.",
  "protocolDocument": {
    "nctId": "NCT02012621",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2013-08-21",
    "uploadDate": "2019-09-13T13:32",
    "size": 137468,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02012621/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 807,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2013-12",
    "completionDate": "2017-07",
    "primaryCompletionDate": "2017-07",
    "firstSubmitDate": "2013-12-04",
    "firstPostDate": "2013-12-16"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* HIV-infected individual.\n* 18 years and older.\n* Taking tenofovir.\n* Blood drawn during regular clinic visit.\n\nExclusion Criteria:\n\n* Refusal to participate.\n* Pregnancy.\n* Inability to provide informed consent.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Adjusted Odds Ratio of Level of Tenofovir-diphosphate (TFV-DP) in Dried Blood Spots (DBS) Associated With Odds of HIV Viral Suppression at All Study Visits",
        "description": "HIV viral load, binary cutoff at assay level of detection (\\<20 copies/mL vs. \\>= 20 copies/mL); reference group: drug concentration (TFV-DP) \\< 350 femtomole (fmol)/punch vs. drug concentration (TFV-DP) \\>= 1850 fmol/punch; adjusted odds ratio calculated using generalized estimating equations; concentration cutoffs established in prior research of healthy volunteers",
        "timeFrame": "Up to 48 Weeks"
      },
      {
        "measure": "Adjusted Odds Ratio of Three-month Self-reported Adeherence Associated With Odds of HIV Viral Suppression at All Study Visits",
        "description": "HIV viral load, binary cutoff at assay level of detection (\\<20 copies/mL vs. \\>= 20 copies/mL); reference group: three-month self-reported adherence \\<28.5% vs. three-month self-reported adherence 100%; adherence cutoffs established in prior research",
        "timeFrame": "Up to 48 Weeks"
      },
      {
        "measure": "Adjusted Odds Ratio of Level of Tenofovir-diphosphate (TFV-DP) in Dried Blood Spots (DBS) Associated With Odds of HIV Viral Suppression at Next Study Visit",
        "description": "HIV viral load, binary cutoff at assay level of detection (\\<20 copies/mL vs. \\>= 20 copies/mL); drug concentration (TFV-DP) \\<800 femtomole (fmol)/punch) vs reference group of drug concentration (TFV-DP) \\>= 1650 fmol/punch; adjusted odds ratio calculated using generalized estimating equations",
        "timeFrame": "Up to 48 Weeks"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 3,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 49,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:20.369Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}